Deepak Fertilisers & Petrochemicals Corporation Ltd. Financial Year 2025-26 Results

Consolidated Revenue: ₹11,506 crore
Consolidated PAT: ₹739 crore

Reader Takeaway: Resilient revenue growth faces margin pressure from costs; new projects promise future expansion.

What just happened

Deepak Fertilisers & Petrochemicals Corporation Ltd. reported its financial results for the fiscal year 2025-26. The company achieved a consolidated revenue of ₹11,506 crore, marking a 12% increase compared to the previous year. However, consolidated profit after tax (PAT) saw a decline of 21.8%, settling at ₹739 crore. Operating EBITDA also decreased by 12.5% to ₹1,684 crore.

Why this matters

The results indicate a mixed performance. While revenue growth signals strong demand and market acceptance, the drop in profitability points to challenges from rising input costs, energy prices, and planned maintenance at its ammonia plant. The recommended dividend of ₹10 per share suggests a commitment to shareholder returns amidst these pressures.

The backstory

FY 2025-26 is described as a transition year for Deepak Fertilisers. The company has been undergoing a phase of significant capital investment in expansion projects. Management is now shifting focus towards execution and value realization from these investments.

What changes now

Key capacity expansion projects, including the Brownfield Nitric Acid plant at Dahej and the Greenfield TAN project at Gopalpur, are nearing completion. These are expected to drive future volume growth and improve operating leverage once commissioned in H2 FY 2026-27. Strategic acquisitions in the explosives and mining services sector have also strengthened the company's portfolio.

Risks to watch

Margin pressure due to raw material price volatility and input costs remains a concern, as reflected in the decline of EBITDA margin to 14.63% from 18.73%. The company's net debt to equity ratio increased to 0.65x, indicating higher capital intensity during the investment cycle.

Peer comparison

While specific peer data for FY26 was not provided in the filing, the company's performance in revenue growth suggests it is navigating a competitive chemical and fertiliser market. Sustained market leadership and strategic moves aim to differentiate its offerings.

Context metrics (time-bound)

• Revenue from Operations: ₹11,506 crore in FY 2025-26, up 12% from ₹10,274 crore in FY 2024-25.
• Operating EBITDA: ₹1,684 crore in FY 2025-26, down 12.5% from ₹1,925 crore in FY 2024-25.
• PAT: ₹739 crore in FY 2025-26, down 21.8% from ₹945 crore in FY 2024-25.
• EPS: ₹58.40 in FY 2025-26, down 21.0% from ₹73.95 in FY 2024-25.
• TAN sales: Grew 11% (577 KT).
• Croptek sales: Grew 25%.
• Capital Investment: ₹1,570 crore invested in strategic projects.
• Net Debt to Equity: Increased to 0.65x.
• Dividend Recommended: ₹10 per share.

What to track next

Investors should closely monitor the commissioning timelines and ramp-up of the new Nitric Acid and TAN projects. The company's ability to manage input costs and expand its solutions-led offerings in mining and crop nutrition will be crucial for future profitability and margin improvement.